The upcoming session targets the operational and strategic hurdles inherent in first-in-human and adaptive trial designs. As study complexity rises, sponsors must move beyond simple speed to integrate biomarker strategies and data analytics that inform long-term program viability. The panel will address how to maintain regulatory confidence and high-quality output while compressing traditional development timelines.

Craig Boyle, Vice President of Medical and Clinical Operations, and Associate Medical Director Aishwarya Vyas-Lahar will provide practical frameworks for managing these operational demands. The discussion aims to equip professionals with methods to mitigate risk early in the development lifecycle, ensuring that data-driven insights support faster progression toward clinical milestones. The live event is scheduled for 11am EDT.